News
GRAL
13.81
-0.10%
-0.01
Weekly Report: what happened at GRAL last week (1028-1101)?
Weekly Report · 3d ago
Weekly Report: what happened at GRAL last week (1021-1025)?
Weekly Report · 10/28 12:32
GRAIL Presents Early Results From REFLECTION Real-World Evidence Study; Says Veteran Cohort Had Cancer Signal Detection Rate Consistent With Other Populations That Received MCED Test
Benzinga · 10/23 22:06
Grail presents initial results from study of Galleri multi-cancer detection test
TipRanks · 10/23 22:05
GRAIL PRESENTS INITIAL RESULTS FROM REFLECTION REAL-WORLD EVIDENCE STUDY OF GALLERI® MULTI-CANCER EARLY DETECTION (MCED) TEST AT THE EARLY DETECTION OF CANCER CONFERENCE
Reuters · 10/23 22:00
CEO & Director Of GRAIL Sold 51% Of Their Shares
Simply Wall St · 10/23 12:16
GRAIL APPOINTS SARAH KREVANS TO BOARD OF DIRECTORS
Reuters · 10/21 20:01
Press Release: GRAIL Appoints Sarah Krevans to Board of Directors
Dow Jones · 10/21 20:01
*GRAIL Appoints Sarah Krevans to Bd of Directors
Dow Jones · 10/21 20:01
Weekly Report: what happened at GRAL last week (1014-1018)?
Weekly Report · 10/21 12:26
Guggenheim starts Grail with Neutral on early stage of market
TipRanks · 10/17 14:10
GRAIL INC <GRAL.O>: GUGGENHEIM INITIATES COVERAGE WITH NEUTRAL RATING
Reuters · 10/17 11:19
Grail initiated with a Neutral at Guggenheim
TipRanks · 10/17 10:21
U.S. RESEARCH ROUNDUP-Constellation Energy, Morgan Stanley, Uber
Reuters · 10/17 06:12
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 10/14 20:31
Weekly Report: what happened at GRAL last week (1007-1011)?
Weekly Report · 10/14 13:11
Weekly Report: what happened at GRAL last week (0930-1004)?
Weekly Report · 10/07 12:55
Stock Picks From Seeking Alpha's September 2024 New Analysts
Seeking Alpha · 10/04 12:00
Weekly Report: what happened at GRAL last week (0923-0927)?
Weekly Report · 09/30 12:43
GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success
Seeking Alpha · 09/24 16:41
More
Webull provides a variety of real-time GRAL stock news. You can receive the latest news about Grail Inc through multiple platforms. This information may help you make smarter investment decisions.
About GRAL
GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.